OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Microbiology and Infection is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-12-01 to 2023-12-01.)

Article	Citations
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis	923
COVID-19, SARS and MERS: are they closely related?	733
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study	532
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	479
Follow-up of adults with noncritical COVID-19 two months after symptom onset	460
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis	458
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting	448
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study	425
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China	414
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay	406
Non-specific effects of BCG vaccine on viral infections	332
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19	273
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society	263
Novel SARS-CoV-2 variants: the pandemics within the pandemic	257
COVID-19 pandemic—a focused review for clinicians	253
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis	252
COVID-19: don't neglect antimicrobial stewardship principles!	233
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	227
Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study	224
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain	213
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India	213
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis	210
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults	204
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors	201
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients	194

Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres	192
Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis	190
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis	185
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications	180
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	178
Viable SARS-CoV-2 in various specimens from COVID-19 patients	167
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study	164
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study	163
Female gender is associated with long COVID syndrome: a prospective cohort study	161
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital	155
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans	143
Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection	142
Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens	137
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis	137
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study	134
Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis	131
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline	131
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection	129
Validation of a commercially available SARS-CoV-2 serological immunoassay	128
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results	119
Pathogenesis and management of fracture-related infection	117
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity	116
Post–COVID-19 chronic symptoms: a postinfectious entity?	116
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	114
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	113
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs	111
Anosmia in COVID-19 patients	111
Outbreak of Candida auris infection in a COVID-19 hospital in Mexico	108
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology	104
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China	102
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review	100
Ibuprofen use and clinical outcomes in COVID-19 patients	100
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)	99
2020 list of human papillomavirus assays suitable for primary cervical cancer screening	97
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	97
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients	95
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities	95
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study	94
Understanding the role of bacterial and fungal infection in COVID-19	94
Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review	93
Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection	90
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	90
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study	90
Association of COVID-19 with pregnancy outcomes in health-care workers and general women	89
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study	89
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review	89
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status	88
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study	87
Stigma at the time of the COVID-19 pandemic	87
ESCMID COVID-19 living guidelines: drug treatment and clinical management	86

Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	86
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage	85
Bloodstream infections – Standard and progress in pathogen diagnostics	85
Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis	83
How to interpret and use COVID-19 serology and immunology tests	82
Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study	82
Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy	81
The interface between COVID-19 and bacterial healthcare-associated infections	80
Evolution of viral quasispecies during SARS-CoV-2 infection	79
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort	79
Neurologic manifestations associated with COVID-19: a multicentre registry	79
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients	79
Follow-up of asymptomatic patients with SARS-CoV-2 infection	78
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy	77
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)	77
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study	77
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review	76
Clostridium difficile and One Health	74
Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre	73
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy	73
Current landscape in the discovery of novel antibacterial agents	73
Commercially available molecular tests for human papillomaviruses: a global overview	72
Review of trials currently testing treatment and prevention of COVID-19	72
Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea	71
Risk factors for chronic biofilm-related infection associated with implanted medical devices	70
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns	70
Pulmonary long-term consequences of COVID-19 infections after hospital discharge	70
Excretion of SARS-CoV-2 in human breast milk	70
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients	69
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	69
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients	67
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	66
Necrotizing skin and soft-tissue infections in the intensive care unit	66
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection	65
Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers	64
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples	63
How do I manage nocardiosis?	63
Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection	62
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks	61
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review	59
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital	58
Trained innate immunity and resistance to Mycobacterium tuberculosis infection	58
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis	58
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?	57
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review	57
Machine learning in infection management using routine electronic health records: tools, techniques, and reporting of future technologies	57
Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves	55
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort	55
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine	55
Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship	55
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)	55
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis	55
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients	53
Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies	53
ESCMID rapid guidelines for assessment and management of long COVID	53
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization	53
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	52
Intensive care management of influenza-associated pulmonary aspergillosis	52
SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy	51
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2	51
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications	51
Long COVID-19—it's not over until?	51
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation	51
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del)	50
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study	50
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	50
Corticosteroid administration for viral pneumonia: COVID-19 and beyond	50
Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect	48
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	48
CT lung lesions as predictors of early death or ICU admission in COVID-19 patients	48
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)	48
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients	48
The impact of vaccines on heterologous adaptive immunity	48
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis	47
Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability	47
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19	47
Novel coronavirus: how things are in Wuhan	46
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	46
Digital PCR: a new technology for diagnosis of parasitic infections	45
Serology anno 2021—fungal infections: from invasive to chronic	45

Invasive aspergillosis in patients with severe COVID-19 pneumonia	45
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	45
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study	45
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group	45
Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis	45
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery	44
High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum	44
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton	44
Incidence and mortality of brain abscess in Denmark: a nationwide population-based study	44
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination	44
Update on SARS-CoV-2 seroprevalence: regional and worldwide	43
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting	43
Resurgence of pneumococcal meningitis in Europe and Northern America	43
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19	42
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	42
Antibiotic use in the COVID-19 crisis in Spain	42
Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking	42
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence	42
Multiple-centre clinical evaluation of an ultrafast single-tube assay for SARS-CoV-2 RNA	41
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019	41
Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study	41
Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data	40
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review	40
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives	40
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	40
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes	40
The kinetics of viral load and antibodies to SARS-CoV-2	40
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes	39
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial	39
Co-infection with other respiratory pathogens in COVID-19 patients	39
Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study	39
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study	38
The correct blood volume for paediatric blood cultures: a conundrum?	38
Lower respiratory tract infection in the community: associations between viral aetiology and illness course	38
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis	38
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study	37
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression	37
Culture-independent detection systems for bloodstream infection	37
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)	36
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis	36
Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study	36
Multistate population and whole genome sequence-based strain surveillance of invasive pneumococci recovered in the USA during 2017	36
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis	36
Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity	36
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae	35
Saliva for molecular detection of SARS-CoV-2 in school-age children	35
Multicentric evaluation of BioFire FilmArray Pneumonia Panel for rapid bacteriological documentation of pneumonia	35
Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system	35
Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia	35
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis	35
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community	35
Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection	34
Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study	34
Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 ‘superplasmids’ in clinical carbapenem-resistant Enterobacterales	33
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis	33
How to start an antimicrobial stewardship programme in a hospital	33
Quantifying the transmission of antimicrobial resistance at the human and livestock interface with genomics	33
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis	33
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance	33
Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial	33
Image analysis and artificial intelligence in infectious disease diagnostics	32
Smartphones as mobile microbiological laboratories	32
Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance	32
Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	32
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort	32
Dynamics and predisposition of respiratory viral co-infections in children and adults	32
Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2	31
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay	31
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	31
Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19	31
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	31
Dramatically improved hand hygiene performance rates at time of coronavirus pandemic	31
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonolog	30
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations	30
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19	30
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?	30
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain	30
When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit	30
Molecular diagnosis of polymicrobial brain abscesses with 16S-rDNA-based next-generation sequencing	30
Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey	30
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis	30
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper	30
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	30
How do I manage a patient with enterococcal bacteraemia?	29
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020—a cross-sectional study	29
The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics	29
Advances in the therapy of bacterial bloodstream infections	29
Sample pooling for SARS-CoV-2 RT-PCR screening	29
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries	29
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	29
Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study	29
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients	29
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris	29
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study	28
National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave	28
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	28
Invasive infections with Fusobacterium necrophorum including Lemierre's syndrome: an 8-year Swedish nationwide retrospective study	28
Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial	28
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort	28
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects	28
An update on Toscana virus distribution, genetics, medical and diagnostic aspects	28
Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective c	28
Assessment of prevalence and load of torquetenovirus viraemia in a large cohort of healthy blood donors	28
Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach	28
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation	28
Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospec	28
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations	28
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial	27
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain	27
Microbiology of hip and knee periprosthetic joint infections: a database study	27
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study	27
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers – A multicentre cross-sectional study	27
Not all COVID-19 pandemic waves are alike	27
Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis	27
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain	27
Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae	27
A novel approach for tuberculosis diagnosis using exosomal DNA and droplet digital PCR	27
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis	27
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial	27
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales	27
Relative bradycardia in patients with COVID-19	27
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study	27
Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study	27
Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study	27
Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis	27
Pretomanid for tuberculosis: a systematic review	27
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	26
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	26
Characterization of fungal microbiota on normal ocular surface of humans	26
Aminoglycosides for infective endocarditis: time to say goodbye?	26
Performance evaluation of different strategies based on microscopy techniques, rapid diagnostic test and molecular loop-mediated isothermal amplification assay for the diagnosis of imported malaria	26
SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature	25
Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees	25
Management of infected pancreatic necrosis in the intensive care unit: a narrative review	25
Mycobacterium tuberculosis Beijing genotype strains and unfavourable treatment outcomes: a systematic review and meta-analysis	25
Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review	25
Sample pooling: burden or solution?	25
Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study	25
Patient care experience with utilization of isolation precautions: systematic literature review and meta-analysis	24
Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection	24
The impact of COVID-19 on community antibiotic use in Canada: an ecological study	24
Elimination of hepatitis C in Europe: can WHO targets be achieved?	24
Prospective One Health genetic surveillance in Vietnam identifies distinct blaCTX-M-harbouring Escherichia coli in food-chain and human-derived samples	24
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme	24
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies	24

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	24
Isolation and culture of Methanobrevibacter smithii by co-culture with hydrogen-producing bacteria on agar plates	24
Changing epidemiology of invasive non-typhoid Salmonella infection: a nationwide population-based registry study	24
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis	24
Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii	24
Heterologous effects of vaccination and trained immunity	24
Effect of the coronavirus disease 2019 pandemic on antibiotic use in primary care	24
COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review	24
Antimicrobial stewardship in the emergency department: characteristics and evidence for effectiveness of interventions	24
Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis	24
Mediastinitis in the intensive care unit patient: a narrative review	24
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments	24
Challenges towards serologic diagnostics of emerging arboviruses	23
Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV	23
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update	23
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	23
Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia	23
Nationwide outbreak of invasive listeriosis associated with consumption of meat products in health care facilities, Germany, 2014–2019	23
Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial	23
Tick-borne encephalitis virus vaccination breakthrough infections in Germany: a retrospective analysis from 2001 to 2018	23
Rapid diagnostic tests for infectious diseases in the emergency department	23
Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy	23
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vac	22
The WHO essential medicines list AWaRe book: from a list to a quality improvement system	22
Bone and joint infections of the hand	22
Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures?	22
Investigation of a nosocomial outbreak of coronavirus disease 2019 in a paediatric ward in South Korea: successful control by early detection and extensive contact tracing with testing	22
Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii	22
Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study	22
Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement	22
Long-term neurologic and cognitive outcome and quality of life in adults after pneumococcal meningitis	22
COVID-19 vaccination in Israel	22
Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections	21
Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study	21
Investigating infection management and antimicrobial stewardship in surgery: a qualitative study from India and South Africa	21
The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis	21
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	21
Sniffing animals as a diagnostic tool in infectious diseases	21
A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel	21
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign	21
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study	21
Avian influenza, a new threat to public health in Europe?	21
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	21
Caring for older adults during the COVID-19 pandemic	21
Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19	21
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing	21
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China	21
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)	21
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study	21
Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex	21
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study	20
Prophylaxis for COVID-19: a systematic review	20
Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study	20
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults	20
Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study	20
Antifungal activity of nitroxoline against Candida auris isolates	20
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study	20
One Health: a multifaceted concept combining diverse approaches to prevent and control antimicrobial resistance	20
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis	20
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study	20
Short-course antibiotics for common infections: what do we know and where do we go from here?	20
FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort	20
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations	20
Evaluation of early clinical failure criteria for gram-negative bloodstream infections	19
Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods	19
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff values	19
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection	19
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents	19
EUCAST evaluation of 21 brands of Mueller–Hinton dehydrated media for disc diffusion testing	19
Gender disparities in coronavirus disease 2019 clinical trial leadership	19
Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan	19
Evaluating integrated surveillance of antimicrobial resistance: experiences from use of three evaluation tools	19
Interventions for rapid recognition and treatment of sepsis in the emergency department: a narrative review	19
Childhood COVID-19: a multicentre retrospective study	19
A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients	19
From genotype to antibiotic susceptibility phenotype in the order Enterobacterales: a clinical perspective	19
Candida blankii: an emerging yeast in an outbreak of fungaemia in neonates in Delhi, India	19
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273	19
PRAISE: providing a roadmap for automated infection surveillance in Europe	19
Digital microbiology	18
Influenza increases invasive meningococcal disease risk in temperate countries	18
Comparative genomic analysis reveals a high prevalence of inter-species in vivo transfer of carbapenem-resistance plasmids in patients with haematological malignancies	18
A prospective prediction tool for understanding Crimean–Congo haemorrhagic fever dynamics in Turkey	18
High prevalence of heterotopic ossification in critically ill patients with severe COVID-19	18
Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy	18
Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of nonresearch payments from the Open Payments Database between 2014 and 2020	18
Unconventional diagnostic tests for Lyme borreliosis: a systematic review	18
SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient	18
Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak	18
Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants	18
More than loss of taste and smell: burning watering eyes in coronavirus disease 2019	18
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes	18
National case fatality rates of the COVID-19 pandemic	18
Mucosal immunity to SARS-CoV-2: a clinically relevant key to deciphering natural and vaccine-induced defences	18
Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults	18
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria	18
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria	18
Evidence for re-infection and persistent carriage of Shigella species in adult males reporting domestically acquired infection in England	18
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study	18
Impact of COVID-19 pandemic on tuberculosis care in India	17
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study	17
Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study	17
Awareness, acceptance, and adoption of the national digital contact tracing tool post COVID-19 lockdown among visitors to a public hospital in Singapore	17
A simplified blood culture sampling protocol for reducing contamination and costs: a randomized controlled trial	17
Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018	17
Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study	17
Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial	17
Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans	17
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positi	17
Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study	17
Treatment of hepatitis D: an unmet medical need	17
Interactions between antiretroviral therapy and complementary and alternative medicine: a narrative review	17
Diagnostic accuracy of rapid nucleic acid tests for group A streptococcal pharyngitis: systematic review and meta-analysis	17
Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study	17
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak—the CoNAN study	17
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial	17
Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples	17
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial	17
Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection	17
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	17
Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022	17
First-generation oral antivirals against SARS-CoV-2	17
Post-discharge oral antimicrobial use among hospitalized patients across an integrated national healthcare network	17
Low rate of severe acute respiratory syndrome coronavirus 2 spread among health-care personnel using ordinary personal protection equipment in a medium-incidence setting	17
The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function	17
Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in asymptomatic individuals and es	17
Antibiotics: easier to start than to stop? Predictors of antimicrobial stewardship recommendation acceptance	17
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)	17
Measles-related hospitalizations and associated complications in Jerusalem, 2018–2019	17
Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings	16
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	16
Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients	16
Information technology aspects of large-scale implementation of automated surveillance of healthcare-associated infections	16
Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria	16
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France	16
Timing of antibiotics in septic patients: a prospective cohort study	16
How scientists and physicians use Twitter during a medical congress	16
Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms	16
Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningiti	16
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents	16
Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: a multicentre European study	16
Validity of surrogate endpoints assessing central venous catheter-related infection: evidence from individual- and study-level analyses	16
Impact of rapid microbial identification on clinical outcomes in bloodstream infection: the RAPIDO randomized trial	16
Invasive group B Streptococcus infections in non-pregnant adults: a retrospective study, France, 2007–2019	16
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime–avibactam due to a deletion in the blaKPC3 gene	16
Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus	16
A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs	16
Evaluation of financial conflicts of interest and drug statements in the coronavirus disease 2019 clinical practice guideline in Japan	16
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission	16
Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity	16
Seroprevalence of Lyme borreliosis in Finland 50 years ago	16
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	16
Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014–2018 national laboratory surveillance	16
How does Pseudomonas aeruginosa affect the progression of bronchiectasis?	16